EUVIMEDEUVIMED entdecken
Crossref

Tricuspid Valve Regurgitation Following Stylet Lumen‐Less Active Fixation Lead or Leadless Pacemaker Implantation

Kotoko Kawaguchi, Satoshi Oka, Nobuhiko Ueda, Tsukasa Oshima, Akinori Wakamiya, Mitsuru Wada, Kohei Ishibashi, Kengo Kusano

Pacing and Clinical Electrophysiology · 31.07.2026

DOI: 10.1111/pace.70372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, online erschienen am 31.07.2026. Verfasst von Kotoko Kawaguchi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tricuspid valve regurgitation (TR) progression is a recognized complication of cardiac‐implantable electronic devices. Implanting a leadless pacemaker (LLPM) or using a 4.1Fr stylet lumen‐less transvenous lead may lower the risk of TR progression compared to conventional 5–7Fr transvenous leads; however, the optimal strategy remains unclear. This study aimed to evaluate TR progression following those two approaches.

Methods

A retrospective comparison was conducted between patients receiving an LLPM ( n = 27) and those implanted with a 4.1Fr transvenous right ventricular lead ( n = 190). The primary outcome was the prevalence of significant TR, defined as moderate or severe TR, at 12 months post‐implantation. The secondary outcome was the incidence of TR progression, defined as a worsening of ≥1 grade between baseline and 12 months post‐implantation.

Results

Baseline TR severity did not differ significantly between the two groups. At the 12‐month follow‐up, the prevalence of significant TR remained comparable between the LLPM and 4.1Fr lead groups (15% vs. 12%, p = 0.54). While most patients in both groups experienced either no change or a one‐grade worsening in TR severity, the LLPM group demonstrated a significantly higher incidence of TR progression compared to the 4.1Fr lead group (33% vs. 16%, p = 0.034). Multivariate analysis identified left ventricular ejection fraction

Schlagwörter

Stichwörter der Autor:innen

4.1Fr transvenous leadarrhythmiascardiac implantable electronic deviceheart failureleadless pacemakertricuspid valve regurgitation

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Zitieren

APA

Kawaguchi, K., Oka, S., Ueda, N., Oshima, T., Wakamiya, A., Wada, M., Ishibashi, K., & Kusano, K. (2026). Tricuspid Valve Regurgitation Following Stylet Lumen‐Less Active Fixation Lead or Leadless Pacemaker Implantation. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70372

Vancouver

Kawaguchi K, Oka S, Ueda N, Oshima T, Wakamiya A, Wada M, et al. Tricuspid Valve Regurgitation Following Stylet Lumen‐Less Active Fixation Lead or Leadless Pacemaker Implantation. Pacing and Clinical Electrophysiology. 2026. doi:10.1111/pace.70372

BibTeX
@article{Kawaguchi2026,
  author = {Kawaguchi, Kotoko and Oka, Satoshi and Ueda, Nobuhiko and Oshima, Tsukasa and Wakamiya, Akinori and Wada, Mitsuru and Ishibashi, Kohei and Kusano, Kengo},
  title = {Tricuspid Valve Regurgitation Following Stylet Lumen‐Less Active Fixation Lead or Leadless Pacemaker Implantation},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2026},
  doi = {10.1111/pace.70372}
}
Kostenlos starten →